Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Gross Profit

Adverum Biotechnlgs Gross Profit Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Gross Profit from 2013 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Adverum Biotechnlgs Gross Profit for the quarter ending June 06, 2020 was $-19m a 49.45% decrease of -9m year over year
  • Adverum Biotechnlgs Gross Profit for the last 12 months ending June 06, 2020 was $-55m a 31.74% decrease of -17m year over year
  • Adverum Biotechnlgs Annual Gross Profit for 2019 was $-40m a -20.79% increase of 8m from 2018
  • Adverum Biotechnlgs Annual Gross Profit for 2018 was $-49m a 21.70% decrease of -11m from 2017
  • Adverum Biotechnlgs Annual Gross Profit for 2017 was $-38m a 24.15% decrease of -9m from 2016
Other Income Statement Metrics:
  • Adverum Biotechnlgs EBITDA for the quarter ending December 12, 2018 was $-21m a 18.17% decrease of -4m year over year
  • Adverum Biotechnlgs Net Income for the quarter ending December 12, 2018 was $-16m a -9.84% increase of 2m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Gross Profit Data

06/2020$-19m
03/2020$-15m
12/2019$-14m
09/2019$-10m
06/2019$-9m
03/2019$-10m
12/2018$-12m
09/2018$-14m
06/2018$-11m
03/2018$-13m

Annual ADVM Gross Profit Data

2019$-40m
2018$-49m
2017$-38m
2016$-29m
2015$-23m
2014$-16m
2013$-2m
2012$-1m